Cargando…

Circ-TRIO promotes TNBC progression by regulating the miR-432-5p/CCDC58 axis

Numerous studies have shown that circRNAs are aberrantly expressed in various cancers and play a significant role in tumor progression. However, the molecular mechanisms of circRNAs in triple-negative breast cancer (TNBC) remain ambiguous. By intersecting throughput data and qRT-PCR results from tis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zekun, Li, Yaming, Yang, Jingwen, Liang, Yiran, Wang, Xiaolong, Zhang, Ning, Kong, Xiaoli, Chen, Bing, Wang, Lijuan, Zhao, Wenjing, Yang, Qifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458743/ https://www.ncbi.nlm.nih.gov/pubmed/36075896 http://dx.doi.org/10.1038/s41419-022-05216-7

Ejemplares similares

Hypoxia‐Induced FUS–circTBC1D14 Stress Granules Promote Autophagy in TNBC
por: Liu, Ying, et al.
Publicado: (2023)

CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR
por: Wang, Xiaolong, et al.
Publicado: (2022)

CircEIF3H-IGF2BP2-HuR scaffold complex promotes TNBC progression via stabilizing HSPD1/RBM8A/G3BP1 mRNA
por: Song, Xiaojin, et al.
Publicado: (2022)

LINC01977 Promotes Breast Cancer Progression and Chemoresistance to Doxorubicin by Targeting miR-212-3p/GOLM1 Axis
por: Li, Zheng, et al.
Publicado: (2021)

circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cells
por: Li, Zheng, et al.
Publicado: (2023)

Targeting the circBMPR2/miR-553/USP4 Axis as a Potent Therapeutic Approach for Breast Cancer
por: Liang, Yiran, et al.
Publicado: (2019)

DGUOK-AS1 acts as a tumorpromoter through regulatingmiR-204-5p/IL-11 axis in breast cancer
por: Liang, Yiran, et al.
Publicado: (2021)

Cancer-associated fibroblasts facilitate breast cancer progression through exosomal circTBPL1-mediated intercellular communication
por: Ye, Fangzhou, et al.
Publicado: (2023)

circHMCU Promotes Proliferation and Metastasis of Breast Cancer by Sponging the let-7 Family
por: Song, Xiaojin, et al.
Publicado: (2020)

circHMCU Promotes Proliferationand Metastasis of Breast Cancerby Sponging the let-7 Family
por: Song, Xiaojin, et al.
Publicado: (2021)

The involvement of the circFOXM1–miR–432–Gα12 axis in glioma cell proliferation and aggressiveness
por: Gong, Yong, et al.
Publicado: (2022)

CircRNA DUSP16 Knockdown Suppresses Colorectal Cancer Progression by Regulating the miR-432-5p/E2F6 Axis
por: Wang, Guangyao, et al.
Publicado: (2021)

HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer
por: Liang, Yiran, et al.
Publicado: (2023)

CircINTS4 Facilitates Chemoresistance of TNBC by Competitively Binding miR-129-5p/POM121 Axis
por: Tang, Qian, et al.
Publicado: (2022)

CircCCDC66: Emerging roles and potential clinical values in malignant tumors
por: Wang, Xiaoxiao, et al.
Publicado: (2023)

Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD
por: Luo, Dan, et al.
Publicado: (2023)

Roles of miR-432 and circ_0000418 in mediating the anti-depressant action of ADAR1
por: Zhang, Xiaonan, et al.
Publicado: (2021)

A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer
por: Liang, Yiran, et al.
Publicado: (2018)

LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
por: Liang, Yiran, et al.
Publicado: (2020)

circ_100984‐miR‐432‐3p axis regulated c‐Jun/YBX‐1/β‐catenin feedback loop promotes bladder cancer progression
por: Tong, Liang, et al.
Publicado: (2021)

Histologic heterogeneity predicts patient prognosis of HER2‐positive metastatic breast cancer: A retrospective study based on SEER database
por: Wang, Yajie, et al.
Publicado: (2023)

Retraction Note to: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
por: Liang, Yiran, et al.
Publicado: (2022)

Huaier Suppresses Breast Cancer Progression via linc00339/miR-4656/CSNK2B Signaling Pathway
por: Wang, Wei, et al.
Publicado: (2019)

circRNA432 enhances the coelomocyte phagocytosis via regulating the miR-2008-ELMO1 axis in Vibrio splendidus-challenged Apostichopus japonicus
por: Fu, Xianmu, et al.
Publicado: (2023)

Integrated analysis identifies a novel lncRNA prognostic signature associated with aerobic glycolysis and hub pathways in breast cancer
por: Li, Zheng, et al.
Publicado: (2021)

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer
por: Liu, Ying, et al.
Publicado: (2020)

The E3 Ligase TRIM4 Facilitates SET Ubiquitin‐Mediated Degradation to Enhance ER‐α Action in Breast Cancer
por: Han, Dianwen, et al.
Publicado: (2022)

Circular RNA circRNA-0039459 promotes the migration, invasion, and proliferation of liver cancer cells through the adsorption of miR-432
por: Zhou, Wenyong, et al.
Publicado: (2022)

Biallelic Variants in CCDC39 Gene Lead to Primary Ciliary Dyskinesia and Kartagener Syndrome
por: Shi, Xiao, et al.
Publicado: (2022)

Identification of a Six-Immune-Related Long Non-coding RNA Signature for Predicting Survival and Immune Infiltrating Status in Breast Cancer
por: Li, Zheng, et al.
Publicado: (2020)

PPP2R2B downregulation is associated with immune evasion and predicts poor clinical outcomes in triple-negative breast cancer
por: Li, Zheng, et al.
Publicado: (2021)

A novel molecular mechanism mediated by circCCDC134 regulates non‐small cell lung cancer progression
por: Tong, Zhufeng, et al.
Publicado: (2023)

Hierarchical assembly of centriole subdistal appendages via centrosome binding proteins CCDC120 and CCDC68
por: Huang, Ning, et al.
Publicado: (2017)

circCCDC66 promotes thyroid cancer cell proliferation, migratory and invasive abilities and glycolysis through the miR-211-5p/PDK4 axis
por: Ren, Hong, et al.
Publicado: (2021)

Chemotherapy with ceramide in TNBC
por: Legembre, Patrick, et al.
Publicado: (2015)

GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

Landscape of RB1 alterations in 22,432 Chinese solid tumor patients
por: Xu, Guanghui, et al.
Publicado: (2022)

Identification of Immune-Related Risk Characteristics and Prognostic Value of Immunophenotyping in TNBC
por: Yi, Jiarong, et al.
Publicado: (2021)

Model for predicting immunotherapy based on M2 macrophage infiltration in TNBC
por: Wu, Haoming, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5dhe29icdhjv15u9gjk2540rp0